The degree of hunger reduction experienced can differ substantially between individuals, and some patients may notice minimal changes to their baseline appetite despite being on a therapeutic dose
That can make microdosing attractive for people who are nervous about side effects, sensitive to medications, or interested in a slower and more conservative approach
Here's why that's BS: By the time glucose tests show abnormalities, you've likely had insulin resistance for years
The prescribing information for all GLP-1 medications explicitly states that missed doses should not be compensated for by increasing subsequent doses
3 One study (an extension of the original STEP-1 trial) also showed that participants regained two-thirds of their weight after discontinuing semaglutide, suggesting that maintaining weight loss may require long-term use
Taking double your prescribed dose can cause severe nausea, vomiting, and potentially dangerous blood sugar drops if you have diabetes
